Loading clinical trials...
Loading clinical trials...
A Phase I/IIa, Multicenter, Open-label, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration
Conditions
Interventions
Intradiscal rhGDF-5
Locations
3
Australia
Hunter Clinical Research
Broadmeadow, New South Wales, Australia
St. George Private Hospital
Kogarah, New South Wales, Australia
BrizBain & Spine, The Wesley Hospital
Auchenflower, Queensland, Australia
Start Date
March 1, 2010
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
February 26, 2016
Lead Sponsor
DePuy Spine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions